These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31606083)

  • 1. Assays for tyrosine phosphorylation in human cells.
    Kruk M; Widstrom N; Jena S; Wolter NL; Blankenhorn JF; Abdalla I; Yang TY; Parker LL
    Methods Enzymol; 2019; 626():375-406. PubMed ID: 31606083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase CK2alpha is a target for the Abl and Bcr-Abl tyrosine kinases.
    Hériché JK; Chambaz EM
    Oncogene; 1998 Jul; 17(1):13-8. PubMed ID: 9671309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and Sensitive Method for Determination of Protein Kinase Activity Based on Surface Charge Change of Peptide-Modified Gold Nanoparticles As Substrates.
    Yi F; Huang X; Ren J
    Anal Chem; 2018 Mar; 90(6):3871-3877. PubMed ID: 29468867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
    Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
    Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the intrinsic kinase activity and substrate specificity of c-Abl and Bcr-Abl.
    Wu JJ; Phan H; Lam KS
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2279-84. PubMed ID: 9873528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.
    Barilá D; Mangano R; Gonfloni S; Kretzschmar J; Moro M; Bohmann D; Superti-Furga G
    EMBO J; 2000 Jan; 19(2):273-81. PubMed ID: 10637231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescence lifetime-based assay for abelson kinase.
    Pritz S; Meder G; Doering K; Drueckes P; Woelcke J; Mayr LM; Hassiepen U
    J Biomol Screen; 2011 Jan; 16(1):65-72. PubMed ID: 21148014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of Bruton's tyrosine kinase by c-Abl.
    Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI
    Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of multiple substrate motifs by the c-ABL protein tyrosine kinase.
    Wu JJ; Afar DE; Phan H; Witte ON; Lam KS
    Comb Chem High Throughput Screen; 2002 Feb; 5(1):83-91. PubMed ID: 11860343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain.
    Duyster J; Baskaran R; Wang JY
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1555-9. PubMed ID: 7533294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Cellular Tyrosine Phosphorylation via Chemical Rescue of Conditionally Active Abl Kinase.
    Wang Z; Kim MS; Martinez-Ferrando I; Koleske AJ; Pandey A; Cole PA
    Biochemistry; 2018 Feb; 57(8):1390-1398. PubMed ID: 29341593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates.
    Brueggemeier SB; Wu D; Kron SJ; Palecek SP
    Biomacromolecules; 2005; 6(5):2765-75. PubMed ID: 16153117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl.
    Mitra A; Sasikumar K; Parthasaradhi BV; Radha V
    Biochim Biophys Acta; 2013 Jan; 1832(1):275-84. PubMed ID: 23124138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.
    Sirvent A; Boureux A; Simon V; Leroy C; Roche S
    Oncogene; 2007 Nov; 26(52):7313-23. PubMed ID: 17533370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target specificity analysis of the Abl kinase using peptide microarray data.
    Rychlewski L; Kschischo M; Dong L; Schutkowski M; Reimer U
    J Mol Biol; 2004 Feb; 336(2):307-11. PubMed ID: 14757045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.
    Mitra A; Radha V
    Oncogene; 2010 Aug; 29(32):4528-42. PubMed ID: 20581864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of paxillin tyrosine phosphorylation via inhibition of c-Abl kinase to protect ventilator induce lung injury in vivo in rats].
    Zhong R; Xiao J; Dai C; Yu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jul; 29(7):596-601. PubMed ID: 28743335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.